Opendata, web and dolomites

S-OS SIGNED

Exosomes as microenvironmental cue for engaging mesenchymal stem cells in osteosarcoma progression

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 S-OS project word cloud

Explore the words cloud of the S-OS project. It provides you a very rough idea of what is the project "S-OS" about.

treatment    decades    identification    progression    behavior    alternative    sites    stroma    molecular    cross    stop    cellular    proteomics    clinical    primarily    interactions    sequencing    childhood    occurs    exosome    reported    os    pro    interference    completely    poorly    genetic    spurt    function    msc    30    altering    metastatic    alterations    revealed    rnas    bioluminescent    last    adolescent    survival    breakthrough    stem    driver    components    adolescence    interaction    explore    deep    tendency    unexplored    wish    lay    secreted    assays    responsible    cells    rapid    recurrence    unsuccessful    microenvironmental    intend    mscs    urgently    communication    therapeutical    stagnated    groundwork    extremely    functional    vesicles    regulatory    prospect    exosomes    develops    educate    stromal    onset    signals    employ    mesenchymal    proved    mortality    mechanisms    osteosarcoma    surprisingly    heterogeneous    tumor    events    intercellular    metastasis    mouse    malignant    trials    explored    tumorigenic    discover    underlying    rate    techniques    bone    aggressive    dismal    talk    proteins    xenograft    models    layer   

Project "S-OS" data sheet

The following table provides information about the project.

Coordinator
STICHTING VUMC 

Organization address
address: DE BOELELAAN 1117
city: AMSTERDAM
postcode: 1081 HV
website: www.vumc.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website http://www.exosomes.nl/
 Total cost 165˙598 €
 EC max contribution 165˙598 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2016
 Duration (year-month-day) from 2016-01-01   to  2017-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    STICHTING VUMC NL (AMSTERDAM) coordinator 164˙679.00
2    STICHTING VU NL (AMSTERDAM) participant 919.00

Map

 Project objective

Osteosarcoma (OS) is a very aggressive malignant bone tumor that develops primarily during childhood and adolescence. It is characterized by rapid growth, a strong tendency for recurrence and an extremely high metastatic potential. In the last three decades OS survival in the presence of metastasis has stagnated at a dismal 30%, clinical trials proved unsuccessful and no major breakthrough in the treatment of OS has been reported. To stop OS mortality, alternative therapeutical approaches urgently need to be explored. Studies into the molecular and cellular events underlying OS revealed complex and heterogeneous genetic alterations, which challenge the prospect of finding and exploiting an unique molecular driver underlying OS. Because OS onset occurs at sites of rapid bone growth during the adolescent growth spurt, microenvironmental factors and tumor stroma may have a defining role in OS development and progression. Surprisingly, the intercellular cross-talk between OS cells and components of the tumor stroma, in particular mesenchymal stem cells (MSCs), have been poorly investigated. Here I intend to demonstrate that tumor secreted vesicles called “exosomes” function as a key microenvironmental factor in OS progression by controlling tumor-stromal cells interactions. Specifically, we aim to explore whether MSC become pro-tumorigenic and pro-metastatic upon interaction with OS exosomes in bioluminescent mouse xenograft models. To identify the molecular signals (i.e. proteins and regulatory RNAs) in OS exosomes responsible for altering MSC behavior, we will employ state-of-the-art proteomics and deep-sequencing techniques. Finally, by means of functional assays we wish to discover the mechanisms by which OS exosome “educate” MSCs. The identification of and interference with this completely unexplored layer of communication will lay the groundwork for novel therapeutical approaches to stop OS high mortality rate.

 Publications

year authors and title journal last update
List of publications.
2018 Maarten P. Bebelman, Martine J. Smit, D. Michiel Pegtel, S. Rubina Baglio
Biogenesis and function of extracellular vesicles in cancer
published pages: , ISSN: 0163-7258, DOI: 10.1016/j.pharmthera.2018.02.013
Pharmacology & Therapeutics 2019-06-18

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "S-OS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "S-OS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

RAMBEA (2019)

Realistic Assessment of Historical Masonry Bridges under Extreme Environmental Actions

Read More  

IRF4 Degradation (2019)

Using a novel protein degradation approach to uncover IRF4-regulated genes in plasma cells

Read More  

PROSPER (2019)

Politics of Rulemaking, Orchestration of Standards, and Private Economic Regulations

Read More